The Federal Trade Commission (FTC) sent Warning Letters to three companies that sell products containing cannabidiol (CBD) and advertise that the products prevent, treat, or cure disease without substantiation of the purported health benefits. The products covered by these warnings letters were oils, tinctures, gummies, and dietary supplements.
Today, the U.S. Food and Drug Administration (FDA) issued a proposed rule that would require health warnings on cigarette packages and advertising. The warnings include color images depicting some of the lesser-known health risks of cigarette smoking. This is FDA’s second attempt to require graphic warnings for cigarette packages and advertisements.
On July 30, 2019, the U.S. Food and Drug Administration (FDA) issued its first Warning Letter to an importer for violations of the Foreign Supplier Verification Program (FSVP) requirements at 21 C.F.R. Part 1, Subpart L (21 C.F.R. §§ 1.500 through 1.514). The Warning Letter was issued to a U.S. importer related to imported tahini implicated in a multi-state Salmonella Concord outbreak in spring 2019.
The U.S. Food and Drug Administration (FDA) recently issued a draft guidance to advise food manufacturers of its intent to exercise enforcement discretion for the name “potassium chloride salt” in the ingredient statement on food labels as an alternative to the common or usual name “potassium chloride.” Potassium chloride is often used as a partial substitute for sodium chloride (i.e. salt) in many foods.
The U.S. Department of Agriculture (USDA) Food Safety Inspection Service (FSIS) has proposed to eliminate requirements that certain meat and poultry products display net weights using a dual declaration format (i.e. requiring that some products declare weight in both pounds and ounces). The proposal would remove the dual net weight declaration for meat or poultry…